News – Page 1142 – Endpoints News

SIGN UP

Reeling Ophthotech eviscerates staff, laying off up to 135; Booming Regeneron adds more space

9 years ago

CRISPR/Cas9 players create an IP alliance as the war with Editas heats up

9 years ago

In a first, AstraZeneca gains rights to an antisense KRAS drug in $165M Ionis deal

9 years ago

Big Pharma’s business model is broken; New drug OKs plunged this year, highlighting an ugly reality

9 years ago

Gilead’s rep takes another punishing blow as a bad, no good, awful year just got worse

9 years ago

Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout

9 years ago

After some careful thinking, Celgene strikes a $295M discovery deal on neurodegeneration

9 years ago

FDA slaps a hold on Agios’ PK drug, forcing the biotech to kill it in favor of an internal rival

9 years ago

TiGenix’s second stab at an IPO bags $36M for late-stage stem cell plans

9 years ago

Can the new CEO at Genentech maintain a tradition of groundbreaking R&D?

9 years ago

Lonza bags Capsugel and its oral drug delivery tech for $5.5B: Biotech vet Truex named COO at Synlogic

9 years ago

Xtandi fails a combo study, blocking a path to continued use for Pfizer, Astellas

9 years ago

Flagship takes on a pioneering new fund — and name — adding $285M to advance its startup mission

9 years ago

Pfizer racks up an FDA approval for eczema blockbuster hopeful crisaborole

9 years ago

New drug OKs fell off a cliff in 2016 and the FDA wants you to know why

9 years ago

INC Research promises 550 new jobs as it plots headquarters move

9 years ago

Analysts track a payer revolt against Sarepta’s controversial Duchenne drug

9 years ago

Pfizer inks an early-stage collaboration deal as it invests in another startup; Stem cell startup lands cardiac tech

9 years ago

Armed with $55M in Third Rock cash, Goldfinch Bio sets out to build a kidney disease pipeline

9 years ago

Stiff-armed by a stubborn Actelion, J&J takes its check book and walks away, leaving an opening for Sanofi

9 years ago

It’s the law: Obama signs widely popular 21st Century Cures Act

9 years ago

Bristol-Myers outlines a big R&D overhaul covering East, West Coast operations

9 years ago

Scott Gottlieb takes a turn in the spotlight for FDA candidates; Triumphant Achaogen lines up stock sale

9 years ago

Kyowa Hakko Kirin hit with a new PhIII setback on an old Parkinson’s drug

9 years ago

First page Previous page 1139 1140 114111421143 1144 1145 Next page Last page